Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Resolve Ophthalmics was a private Florida ophthalmology company associated with University of Miami/Bascom Palmer Eye Institute inventors and focused on ophthalmic imaging and diagnostic technologies. Publicly available disclosures indicate that University of Miami-owned patents and a PCT application related to corneal and anterior segment imaging/diagnostics were licensed to Resolve Ophthalmics. The company appears to have been developing software- and device-oriented ophthalmic tools rather than a traditional therapeutic drug pipeline. Corporate registry data show the entity was formed in 2016 in Florida, but more recent business-registry sources indicate it is inactive. There is no clear evidence from public sources of a clinical-stage drug pipeline, public listing, or acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Resolve Ophthalmics.